SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
LEMAITRE VASCULAR
(NQNM:LMAT Last Sale: 25.28 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (LMAT : $25.28)
$510,113 million Market Cap at Market Close, July 1, 2022
Medical Products SubIndustry up .00% / Health Industry up .00% Today
63 Second Avenue Research Report Earnings Snapshot - Last 10/28/18
Burlington, MA 01803 Fact Sheet
Phone: 781-221-2266 Financial Statements
Peer Comparison
Annual Reports

George W. LeMaitre, Chmn./CEO/Pres., David B. Roberts, CFO
Provider of medical devices for the treatment of peripheral vascular disease. IPO at $7 October 18, 2006. Raised $38.5 million, selling 5.5 million shares, 35% of the outstanding. Lead Manager: Goldman Sachs.
Historical Charts    Technical Analysis
No Historical Data available for LMAT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common LMAT $25.28 $25.28 0 .0 $25 $25.97 124,614 $25 $25.97 20,178,506
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $510,112,632

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex